YSIOS CAPITAL
Ysios Capital is a leading Spanish independent venture capital firm that provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages c.a. €350 M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies.
YSIOS CAPITAL
Industry:
Asset Management Finance Financial Services
Founded:
2008-01-01
Status:
Active
Contact:
+34 94 310 82 19
Email Addresses:
[email protected]
Technology used in webpage:
CDMon Hosting
Similar Organizations
Cormorant Asset Management
Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles.
Janus Henderson Investors
Janus Henderson Investors is an asset manager that helps their clients achieve their financial goals.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-05-29 | ADCendo | Ysios Capital investment in Series A - ADCendo | 16 M EUR |
| 2024-05-07 | Memo Therapeutics | Ysios Capital investment in Series C - Memo Therapeutics | 20 M CHF |
| 2024-03-19 | Engrail Therapeutics | Ysios Capital investment in Series B - Engrail Therapeutics | 157 M USD |
| 2024-02-08 | Neurona Therapeutics | Ysios Capital investment in Series E - Neurona Therapeutics | 120 M USD |
| 2023-11-07 | Kynexis | Ysios Capital investment in Series A - Kynexis | 57 M EUR |
| 2023-08-14 | Xeltis | Ysios Capital investment in Series D - Xeltis | 12.5 M EUR |
| 2023-06-22 | Tagworks Pharmaceuticals | Ysios Capital investment in Series A - Tagworks Pharmaceuticals | 65 M USD |
| 2023-05-25 | VarmX | Ysios Capital investment in Series B - VarmX | 30 M GBP |
| 2023-04-04 | ADCendo | Ysios Capital investment in Series A - ADCendo | 31 M EUR |
| 2022-09-14 | SparingVision | Ysios Capital investment in Series B - SparingVision | 75 M EUR |
More informations about "Ysios Capital"
About us – Ysios Capital
Ysios Capital was founded in 2008 and has offices in San Sebastian and Barcelona. With more than €400M AUM, we are the largest life sciences venture capital firm in Spain, with our investment successes providing a significant …See details»
Ysios Capital - Crunchbase Investor Profile & Investments
Ysios Capital is a leading Spanish independent venture capital firm that provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic …See details»
Ysios Capital - Investments, Portfolio & Company Exits - Crunchbase
Ysios Capital 's most notable exits include Aura Biosciences, CVRx, and Mineralys Therapeutics. Which industries has this organization had the most exits in? Show . Aura Biosciences Aura …See details»
Ysios Capital - LinkedIn
Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform ...See details»
Our Portfolio - Ysios Capital
Ysios Capital Partners participates in Biovex’s $70million final closing. Company News. CorWave France. CorWave. CorWave is a French medtech company developing next-generation blood pumps for heart failure patients. Region. …See details»
Ysios Capital investment portfolio - PitchBook
Ysios Capital General Information Company Description. Founded in 2008, Ysios Capital is a venture capital firm based in San Sebastián, Spain. The firm seeks to invest in biotech …See details»
Ysios Capital - EU-Startups
Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform …See details»
Ysios Capital Closes its Third Fund at €216 Million …
May 26, 2021 Contacts. Ysios Capital Míriam Cortés, tel.: +34 93 517 3545, [email protected] Instinctif Partners Melanie Toyne-Sewell / Kaj Sahota / Nathan Billis, tel.: +44 207 457 2020, Ysios ...See details»
Ysios Capital - Org Chart, Teams, Culture & Jobs - The Org
Ysios Capital is a leading Spanish independent venture capital firm that provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic …See details»
List of top Ysios Capital Portfolio Companies - Crunchbase
Feb 19, 2011 Ysios Capital is a leading life sciences investor financing highly innovative companies worldwide. This list of organizations invested in by Ysios Capital provides data on …See details»
Ysios Capital closes third fund at €216M – Ysios Capital
May 26, 2021 Ysios Capital closes its third fund at €216 million ($260 million) Ysios BioFund III (YBF III) is the firm’s largest fund to date. To invest in up to 15 companies in Europe and the …See details»
Ysios Capital raises €155M for 3rd fund - S&P Global
Jun 11, 2020 Spanish venrture capital firm Ysios Capital Partners SGEIC SAU raised € 155 million for its third fund.. Ysios Biofund III FCRE, which aims to raise € 200 million, will invest …See details»
Spanish VC Ysios bags €216M to build EU-skewed biotech portfolio
May 25, 2021 Ysios Capital has closed its third fund at €216 million ($265 million). The fund, the largest raised by Ysios to date, equips the Spanish VC shop to invest in up to 15 companies in …See details»
Ysios Capital - Recent News & Activity - Crunchbase
May 29, 2024 Life-Sciences-Europe — Adcendo–Ysios Capital: investment, 202304 financing round Series A extension totalling €31m incl existing + co-lead investor Ysios Capital News • …See details»
Investment Strategy – Ysios Capital
We invest in both asset-centric companies and product-enabling platform technologies with a proprietary pipeline. We are agnostic to the therapeutic modality and our investments feature …See details»
NorthSea Therapeutics Completes US$80 Million Series C …
Dec 17, 2021 The financing round was co-led by Ysios Capital and Forbion Growth and joined by new investors; a large managed care organization, and Hercules Capital, Inc. (NYSE: HTGC).See details»
The Team – Ysios Capital
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of …See details»
Ysios Capital - Contacts, Employees, Board Members ... - Crunchbase
Ysios Capital has 9 current employee profiles, including Managing Partner and Co - Founder Joel Jean Mairet. Ysios Capital has 1 board member or advisor, Cristina Garmendia. Contacts. Edit …See details»
Join Us - Ysios Capital
If you have a PhD in life sciences and are passionate about drug development, the Ysios Capital fellowship programme is a great opportunity to get involved. We seek individuals with a strong …See details»